Medicinal product name Mirapexin
Pharmaceutical form Tablet
Strength 0.088 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code N04BC05 Anti-parkinson drugs

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(0,088 mg)
PA/Al/PVC blister    EU/1/97/051/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/97/051/002
Date of authorisation Feb 23, 1998
Marketing authorisation holder, country Boehringer Ingelheim International GmbH, Germany